Taro Pharmaceutical Industries Ltd (TARO) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Taro Provides Results for December 31, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine...

Taro to Release Third Quarter Results on January 25, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Taro Announces Merger Agreement with Sun Pharma

Taro Announces Merger Agreement with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, Jan. 17, 2024 Agreed...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Taro Provides Results for September 30, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six...

Taro to Release Second Quarter Results on October 26, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Taro Provides Results for the Quarter Ended June 30, 2023

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June...